BE Pharma Management
Board
2 directors, no change since 2025Statutory director
since 01-06-2015
term without a fixed end
earlier manager, until 05-07-2019
listed in the 2025 annual accounts, filed on 16-07-2026
Director (not named in the articles)
since 01-10-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 16-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 05-07-2019
Mandates through the years
2 names, the dashed line is todayStatutory director
Director (not named in the articles)
BoardEarlier
Mandates as a list
-
- Statutory manager, appointed by deed of 26-05-2015, until 05-07-2019
- Statutory director, appointed by deed of 05-07-2019, still in office
-
- Director (not named in the articles), from 01-10-2025 to date
Control
Founders
,
This company
BE Pharma Management
Equity €194,360
Profit €45,003 in 2025
Capital
- Contribution
- €118,600
- Shares
- 100 in the deed of 26-05-2015
- Source
- deed of 05-07-2019
Articles of association
deed of 05-07-2019 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 20 May at 20:00
Shareholders
After the capital increase
deed of 14-09-2015 ↗
- €99,000 · contanten
- €1,000 · contanten
At incorporation
deed of 26-05-2015 ↗
- founder
- founder
Capital transactions
Capital over time
- 05-07-2019 Converted to unavailable equity · €118,600
- 14-09-2015 Capital increase of €100,000 · to €118,600 · contanten
- 26-05-2015 Incorporation · €18,600 · 100 shares